Clinical Trial Update: Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing ablation to antiarrhythmic drug therapy in patients with persistent atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Hospital Clinic of Barcelona | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED